Novavax stock plummeted Friday after the U.S. Food and Drug Administration said there were risks of possible heart inflammation tied to the company’s Covid-19 vaccine. The data was released …
https://www.barrons.com/articles/novavax-nvax-covid-19-vaccine-fda-heart-inflammation-51654268921

